0000950170-24-123611.txt : 20241107 0000950170-24-123611.hdr.sgml : 20241107 20241107190042 ACCESSION NUMBER: 0000950170-24-123611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241107 FILED AS OF DATE: 20241107 DATE AS OF CHANGE: 20241107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Wendy B. CENTRAL INDEX KEY: 0002042847 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42121 FILM NUMBER: 241437569 MAIL ADDRESS: STREET 1: RAPPORT THERAPEUTICS, INC. STREET 2: 1325 BOYLSTON STREET, SUITE 401 CITY: BOSTON STATE: MA ZIP: 02215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rapport Therapeutics, Inc. CENTRAL INDEX KEY: 0002012593 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880724208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 401 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: 857-321-8020 MAIL ADDRESS: STREET 1: 1325 BOYLSTON STREET STREET 2: SUITE 401 CITY: BOSTON STATE: MA ZIP: 02215 4 1 ownership.xml 4 X0508 4 2024-11-07 0002012593 Rapport Therapeutics, Inc. RAPP 0002042847 Young Wendy B. RAPPORT THERAPEUTICS, INC. 1325 BOYLSTON STREET, SUITE 401 BOSTON MA 02215 true false false false false Stock Option (Right to Buy) 26.9 2024-11-07 4 A false 29756 0 A 2034-11-07 Common Stock 29756 29756 D One-third of the shares underlying this option shall vest and become exercisable on November 7, 2025, with the remaining shares vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. /s/ Troy Ignelzi, Attorney-in-Fact 2024-11-07